EFEarnings Feed

C

Company dossier

CASI Pharmaceuticals, Inc (DE)

CIK 0000895051SIC 2836Biological Products, (No Diagnostic Substances)

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

7 items

10-QAccepted Nov 11, 7:00 PM ETAcc 0000950133-99-003523
ENTREMED INC138.4 KB
ENTREMED INC 10-Q
View filing
10-QAccepted Aug 15, 8:00 PM ETAcc 0000950133-99-002826
ENTREMED INC99.4 KB
ENTREMED INC 10-Q
View filing
8-KAccepted Aug 9, 8:00 PM ETAcc 0000950133-99-002651
ENTREMED INC223.5 KB
ENTREMED INC 8-K
View filing
10-QAccepted May 16, 8:00 PM ETAcc 0000950133-99-001874
ENTREMED INC34.5 KB
ENTREMED INC 10-Q
View filing
8-KAccepted Feb 10, 7:00 PM ETAcc 0001024739-99-000053
ENTREMED INC12.5 KB
ENTREMED INC 8-K
View filing
10-QAccepted Oct 29, 7:00 PM ETAcc 0000950133-98-003638
ENTREMED INC44.9 KB
ENTREMED INC 10-Q
View filing
10-QAccepted Aug 11, 8:00 PM ETAcc 0000950133-98-002973
ENTREMED INC38.2 KB
ENTREMED INC 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
9620 MEDICAL CENTER DR STE 300
ROCKVILLE, MD, 20850
mailing
9620 MEDICAL CENTER DR STE 300
ROCKVILLE, MD, 20850

Former names

CASI Pharmaceuticals, Inc.
2014-08-14 – 2023-02-21
ENTREMED INC
1996-05-14 – 2014-06-13